Investigation of residues in the fibrin(ogen) γ chain involved in tissue plasminogen activator binding and plasminogen activation

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 6, 2004, Pages 451-461

  Wilhelm, Susan E ^a   Lounes, Karim C ^b   Lord, Susan T ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Binding; Fibrin(ogen); Plasminogen; Tissue plasminogen activator

Indexed keywords

ALANINE; AMINO ACID DERIVATIVE; FIBRIN; FIBRINOGEN; FIBRINOGEN VARIANT; PLASMIN; POLYMER; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BINDING AFFINITY; CATALYSIS; ENZYME ACTIVITY; ENZYME BINDING; PLASMINOGEN ACTIVATION; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SUBSTITUTION; FIBRINOGEN; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; HUMANS; MUTAGENESIS, SITE-DIRECTED; PLASMIN; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; TISSUE PLASMINOGEN ACTIVATOR;

EID: 4444286155     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200408000-00003     Document Type: Article

References (42)

1. Doolittle RF. Fibrinogen and fibrin. Annu Rev Biochem 1984; 53:195-229.
2. Doolittle RF. Structural basis of the fibrinogen-fibrin transformation: contributions from X-ray crystallography. Blood Rev 2003; 17:33-41.
3. Mosesson MW. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly. Blood Coagul Fibrinolysis 1997; 8:257-267.
4. Laudano AP, Doolittle RF. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry 1980; 19:1013-1019.
5. Olexa SA, Budzynski AZ. Evidence for four different polymerization sites involved in human fibrin formation. Proc Natl Acad Sci USA 1980; 77:1374-1378.
6. Hantgan RR, Hermans J. Assembly of fibrin. J Biol Chem 1979; 254:11272-11281.
7. Weisel JW. Fibrin assembly: lateral aggregation and the role of the two pairs of fibrinopeptides. Biophys J 1986; 50:1079-1093.
8. Lijnen HR, Collen D. Mechanisms of physiological fibrinolysis. Baillieres Clin Haematol 1995; 8:277-290.
9. Rijken DC. Plasminogen activators and plasminogen activator inhibitors: biochemical aspects. Baillieres Clin Haematol 1995; 8:291-312.
10. Pointing C, Marshall, JM, Cederholm-Williams, SA. Plasminogen: a structural review. Blood Coagul Fibrinolysis 1992; 3:605-614.
11. Marder VJ, Francis CW. Plasmin degradation of cross-linked fibrin. Ann NY Acad Sci 1983; 408:397-406.
12. Walker JB, Nesheim ME. The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin. J Biol Chem 1999; 274:5201-5212.
13. Meh DA, Mosesson MW, DiOrio JP, Siebenlist KR, Hernandez I, Amrani DL, et al. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis. Blood Coagul Fibrinolysis 2001; 12:627-637.
14. Tsurupa G, Medved L. Identification and characterization of novel t-PA-and plasminogen-binding sites within fibrin(ogen) αC-domains. Biochemistry 2001; 40:801-808.
15. Grailhe P, Nieuwenhuizen W, Angles-Cano E. Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen. Eur J Biochem 1994; 219:961-967.
16. Nieuwenhuizen W, Vermond A, Voskuilen M, Traas DW, Verheijen JH. Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator. Biochim Biophys Acta 1983; 748:86-92.
17. Voskuilen M, Vermond A, Veeneman GH, van Boom JH, Klasen EA, Zegers ND, et al. Fibrinogen lysine residue Aα 157 plays a crucial role in the fibrin-induced acceleration of plasminogen activation, catalyzed by tissue-type plasminogen activator. J Biol Chem 1987; 262:5944-5946.
18. Yonekawa O, Voskuilen M, Nieuwenhuizen W. Localization in the fibrinogen γ-chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalysed activation of plasminogen. Biochem J 1992; 283:187-191.
19. Druzhyna JN, Makogonenko E, Yakovlev S. Studies of the t-PA-catalyzed Glu-plasminogen activation on different models of polymeric fibrin. Thromb Res 1997; 87:131-139.
20. Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. J Biol Chem 1982; 257:2912-2919.
21. Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170:1095-1096.
22. Binnie CG, Hettasch JM, Strickland E, Lord ST. Characterization of purified recombinant fibrinogen: partial phosphorylation of fibrinopeptide A. Biochemistry 1993; 32:107-113.
23. Deng WP, Nickoloff JA. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal Biochem 1992; 200:81-88.
24. Lounes KC, Ping L, Gorkun OV, Lord ST. Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that 'B-b' interactions have a role in protofibril formation. Biochemistry 2002; 41:5291-5299.
25. Gorkun OV, Veklich YI, Weisel JW, Lord ST. The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen. Blood 1997; 89:4407-4414.
26. Takabe M, Soe G, Kohno I, Sugo T, Matsuda M. Calcium ion-dependent monoclonal antibody against human fibrinogen: preparation, characterization, and application to fibrinogen purification. Thromb Haemost 1995; 73:662-667.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
28. Mullin JL, Gorkun OV, Lord ST. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism. Biochemistry 2000; 39:9843-9849.
29. Lord ST, Strickland E, Jaycock E. Strategy for recombinant multichain protein synthesis: fibrinogen Bβ-chain variants as thrombin substrates. Biochemistry 1996; 35:2342-2348.
30. Higgins DL, Vehar GA. Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin. Biochemistry 1987; 26:7786-7791.
31. Weisel JW, Veklich Y, Gorkun O. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. J Mol Biol 1993; 232:285-297.
32. Verheijen JH, Mullaart E, Chang GT, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982; 48:266-269.
33. Horrevoets AJ, Smilde A, de Vries C, Pannekoek H. The specific roles of finger and kringle 2 domains of tissue-type plasminogen activator during in vitro fibrinolysis. J Biol Chem 1994; 269:12639-12644.
34. Bosma PJ, Rijken DC, Nieuwenhuizen W. Binding of tissue-type plasminogen activator to fibrinogen fragments. Eur J Biochem 1988; 172:399-404.
35. Stewart RJ, Fredenburgh JC, Weitz JI. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-Dimer noncovalently linked to fragment E. J Biol Chem 1998; 273:18292-18299.
36. Parise L, Steiner B, Nannizzi L, Criss A, Phillips D. Evidence for novel binding sites on the platelet glycoprotem IIb and IIIa subunits and immobilized fibrinogen. Biochem J 1993; 289:445-451.
37. Marguerie G, Edgington T, Plow E. Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem 1980; 255:154-161.
38. Zamarron C, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator. J Biol Chem 1984; 259:2080-2083.
39. Ranby M. Studies on the kinetics of plasminogen activation by tissue plasminogen activator. Biochim Biophys Acta 1982; 704:461-469.
40. Rijken DC, Hoylaerts M, Collen D. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. J Biol Chem 1982; 257:2920-2925.
41. Mosesson MW, Siebenlist KR, Voskuilen M, Nieuwenhuizen W. Evaluation of the factors contributing to fibrin-dependent plasminogen activation. Thromb Haemost 1998; 79:796-801.
42. Yakovlev S, Makogonenko E, Kurochkina N, Nieuwenhuizen W, Ingham K, Medved L. Conversion of fibrinogen to fibrin: mechanism of exposure of t-PA- and plasminogen-binding sites. Biochemistry 2000; 39:15730-15741.